Ahmed Al-Niaimi, MD, of the UW Ob-Gyn Division of Gynecologic Oncology, published “Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations — Part I: Preoperative and intraoperative management” in the European Journal of Surgical Oncology.
In the article, Al-Niaimi and co-authors reviewed available evidence in current perioperative care guidelines:
“Enhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based perioperative care. The aim was to elaborate dedicated recommendations for cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC) in a two-part series of guidelines based on expert consensus. The present part I of the guidelines highlights preoperative and intraoperative management.”
Read the whole article here. Great work, Dr. Al-Niaimi!